John Trizzino
President chez NOVAVAX, INC.
Fortune : 133 706 $ au 31/03/2024
Profil
M. John J. Trizzino est directeur financier, vice-président exécutif, directeur commercial et des affaires chez Novavax, Inc. Auparavant, M. Trizzino a occupé les postes de directeur général et de directeur chez ImmunoVaccine, Inc., de vice-président de la franchise vaccinale chez MedImmune LLC, de vice-président du développement commercial chez ID Biomedical Corp. et de vice-président du développement commercial chez Henry Schein, Inc. Il a également été membre du conseil d'administration de Tech Council of Maryland, Inc. Il a obtenu son diplôme de premier cycle à l'université de Long Island et un MBA à la Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVAVAX, INC.
0,02% | 10/03/2024 | 27 972 ( 0,02% ) | 133 706 $ | 31/03/2024 |
Postes actifs de John Trizzino
| Sociétés | Poste | Début |
|---|---|---|
| NOVAVAX, INC. | President | 20/11/2023 |
Anciens postes connus de John Trizzino
| Sociétés | Poste | Fin |
|---|---|---|
| IMV INC. | Chief Executive Officer | 01/09/2013 |
| NOVAVAX, INC. | Corporate Officer/Principal | 06/09/2011 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2009 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2009 |
| HENRY SCHEIN, INC. | Corporate Officer/Principal | 01/01/2004 |
Formation de John Trizzino
| Long Island University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HENRY SCHEIN, INC. | Distribution Services |
| NOVAVAX, INC. | Health Technology |
| IMV INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
